632 research outputs found
2019 Liffman Lecture - Ethical Philanthropy - How do we do better at doing good?
The second annual Liffman Lecture was held at Melbourne Town Hall on 7 May 2019. Swinburne and the Swinburne Philanthropy and Social Impact Alumni (SPSIA) were thrilled to host renowned ethicist Peter Singer AC for his return to Swinburne. Peter was joined in conversation by Peter Mares (senior moderator with the Cranlana Programme, former ABC journalist and broadcaster, author and Adjunct Fellow at the Swinburne Centre for Urban Transitions) and Leigh Mathews (Victorian Young Australian of the Year 2009 and founder of ALTO Global Consulting) for a robust and uncompromising discussion
After the Victorians: The Historical Turning Point in McEwan's On Chesil Beach
This article examines the common view that Ian McEwan's novel On Chesil Beach is an affirmation of the sexual revolution of the 1960s. Instead, the roots of McEwan's ideas are traced back to the Victorian period, locating On Chesil Beach in a thematic tradition with a long pedigree in modern British literature. Through a critical engagement with McEwan's oeuvre, the author examines the moral implications that accompany the notion of a historical turning point.This article was written with the support of a research grant from Hanyang University
Human cloning and embryonic stem cell research after Seoul. [Mathews]
4 pages (out of 249 pages)Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted
Human cloning and embryonic stem cell research after Seoul. [Mathews]
4 pages (out of 249 pages)Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted
Meliphaga phrygia subsp. tregellasi Mathews
<i>Meliphaga phrygia tregellasi</i> Mathews <p> <i>Meliphaga phrygia tregellasi</i> Mathews, 1912a: 402 (Victoria).</p> <p> Now <i>Anthochaera phrygia</i> (Shaw, 1794). See Salomonsen, 1967: 436, Schodde and Mason, 1999: 304, Christidis and Boles, 2008: 185–191, and Higgins et al., 2008: 622–623.</p> <p> HOLOTYPE: <b>AMNH 691851</b>, adult male, collected at Mulgrave, 37.55S, 145.12E (USBGN, 1957), Victoria, Australia, on 3 December 1908, by Thomas Tregellas. From the Mathews Collection (no. 2812) via the Rothschild Collection.</p> <p> COMMENTS: Mathews cited his catalog number of the holotype in the original description and gave the range as ‘‘ Victoria, South Australia.’’ The holotype bears Tregellas’ original label, Mathews and Rothschild type labels, and a ‘‘Figured’’ label, indicating that it is illustrated in Mathews (1924: pl. 525, opp. p. 404, text p. 405), where it is confirmed as the type of <i>tregellasi</i>. The following specimens are paratypes: <b>AMNH 691834</b> (Mathews no. 3153), sex?, Gippsland, undated, (entered in catalog only as ‘‘ Victoria’ ’); <b>AMNH 691837</b> (not found in catalog but collected on same day as next), female, Bayswater, 26 December 1908; <b>AMNH 691838</b> (Mathews no. 3143), female juvenile, Bayswater, 26 December 1908. Three other specimens are possible paratypes, but I did not find them in Mathews’ catalog and do not know when he received them: AMNH 691833, male, Blackwood, South Australia, 8 June 1909; AMNH 691839, male, Melton, 6 February 1905; AMNH 691849, male, Lang Lang, 1898. AMNH 691850 (14718) Moorabool, December 1895, is not a paratype, as it was not cataloged by Mathews until 5 November 1912, after the 31 January 1912 publication date of <i>tregellasi</i>. Other specimens in AMNH were collected too late or were never in Mathews’ collection.</p> <p> This species is usually placed in the genus <i>Xanthomyza</i>; but based on their phylogenetic analysis of molecular data from their studies on the Meliphagidae, Driskell and Christidis (2004: 953) merged the genus <i>Xanthomyza</i> in the genus <i>Anthochaera</i>.</p> <p> McAllan (2007: 140) discussed the spelling of the genus <i>Xanthomyza</i> and decided that the original spelling by Swainson, <i>Zanthomiza</i>, was a valid and available name. Christidis and Boles (2008: 186) and Higgins et al. (2008: 622) accepted this interpretation, without mentioning the subsequent publication by Schodde et al. (2007: 276), pointing out that McAllan had failed to consider the relevant article in the Code (ICZN, 1999: 42, Art. 33.2.3.1), under which ‘‘ <i>Xanthomyza</i> is a justified emendation, with Swainson (1837) as author, after Salomonsen (1967), and should be accepted as the correct spelling.’’ Thus, when the original genus is used in taxonomic lists, the spelling <i>Xanthomyza</i> should be used.</p>Published as part of <i>Mary, 2011, Type Specimens Of Birds In The American Museum Of Natural History Part 9. Passeriformes: Zosteropidae And Meliphagidae, pp. 1-193 in Bulletin of the American Museum of Natural History 2011 (348)</i> on page 15
Encoding Space: Shaping Learning Environments That Unlock Human Potential by Brian Mathews and Leigh Ann Soistmann (review)
Book review positively assesses Mathews and Soistmann\u27s book Encoding Space: Shaping Learning Environments That Unlock Human Potential. The reviewer suggests the book to librarians, interior designers, and others interested in higher education
Adjunctive analgesic therapy
Adjuvant analgesics are drugs that have weak or nonexistent analgesic action when administered alone but can enhance analgesic actions when coadministered with known analgesic agents. Such agents are often administered in cases of refractory pain. For some chronic pain syndromes, however, they may constitute a first-line approach. Because pain is such an individual experience, analgesic regimens may require several drugs at varying dosages to confer a comfortable state. Adjunctive therapies such as the tricyclic antidepressants, anticonvulsants, N-methyl-D-aspartic acid receptor antagonists and low-dose intravenous local anesthetics, to name a few, have proved to be efficacious in relieving certain types of pain, especially neuropathic and cancer pain. Their use in animals is increasing, with anecdotal reports of some success.LR: 20051116; PUBM: Print; JID: 7809942; 0 (Analgesics); RF: 57; ppublishSource type: Electronic(1
First Peoples Child & Family Review, Volume 15, Issue 1 (2020)
It is with great pleasure that we bring you Volume 15, Issue 1 of the First Peoples Child & Family Review. Although this issue was not guided by a particular theme, the articles are connected by a common narrative of rights and responsibilities. The articles remind us that we all have a right to participate in matters that affect us and a responsibility to uphold that right for everyone. This includes the right to participate in society and its institutions equitably and in a manner that is relevant to the individual and/or group.
Corresponding author: Brittany Mathews at [email protected]
Robin Mathews and the Canadian dialectic: Forms of nationalist thought in Canada.
Robin Mathews' vision of a Canadian dialectic is a valuable practical concept because it works within a moral framework, inviting discussion at the same time as it creates a specific positive Canadian nationalism. This Canadian dialectic does not presuppose a single, unifying view of Canadian identity, nor does it produce claims to finality. In espousing a view that results in a dialogue between two competing visions, the dialectic fleshes out historic debates which increase their cultural and historical significance and promotes difference. What Mathews argues is that what is important to Canada and Canadian identity is the fact of an ongoing dialectic that is a valid counterpoint to traditionally dominant views of Canadian literature and culture.The original print copy of this thesis may be available here: http://wizard.unbc.ca/record=b160052
- …
